DJIA 18,214.42 -10.15 -0.06%
NASDAQ 4,987.89 20.75 0.42%
S&P 500 2,110.74 -3.12 -0.15%
market minute promo

Biogen Idec (NASDAQ: BIIB)

410.10 1.16 (0.28%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BIIB $410.10 0.28%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $408.82
Previous Close $408.94
Daily Range $406.07 - $411.77
52-Week Range $272.02 - $412.02
Market Cap $96.2B
P/E Ratio 33.06
Dividend (Yield) $0.00 (0.0%)
Volume 863,782
Average Daily Volume 1,604,794
Current FY EPS $16.79




Drug Makers

Biogen Idec (BIIB) Description

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website:

News & Commentary Rss Feed

5 Things Biogen Idec Inc's Management Wants You to Know

Pipeline data, new drug launches, and sales of established drugs top the list.

Short Sellers Increase Bets Against Biotech as Shares Continue to Rise

The Catalysts Biogen Idec Investors Should Watch

3 Stocks Dragging The Drugs Industry Downward

The Most Dominant Stocks in 2015 Taking Nasdaq to 5,000 and Beyond

Evercore ISI Technical Analysis: The 'Single Best Idea'

3 Biotech Stocks I'd Love to Stash Away in My Portfolio Forever

Celgene Corporation, Gilead Sciences, and Biogen Idec are three names that I want to own for the long haul.

Seeking Alpha's Biotech Weekly: Sanofi's New Chief, Sarissa Shakes Ariad, And More

Comparing America's Next 3 Biotechnology Companies

My Top Biotechnology Stocks For 2015

See More BIIB News...

BIIB's Top Competitors

BIIB $410.10 (0.28%)
Current stock: BIIB
AMGN $158.97 (0.56%)
Current stock: AMGN
GILD $104.19 (-0.23%)
Current stock: GILD
$0.00 (0.00%)
Current stock: